$1.540
+0.020 (+1.32%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ACTU Prediction & Forecast by Similar Chart Analysis
Alphio's ACTU stock price prediction model matches the current Actuate Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.56 (+1.26%). The 1-week path is $1.53 (-0.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Actuate Therapeutics Inc Stock?
Actuate Therapeutics Inc (ACTU) appears to be a good buy right now due to its recent positive clinical trial results, which have driven a 30.31% increase in stock price over the last five days. The stock is currently priced at $1.66, with a projected trajectory suggesting a potential increase of 163.80% based on historical patterns. However, the company has reported significant net losses, with a net income of -5,626,749 USD in Q1 2026, indicating ongoing financial challenges. The main risk is its high volatility, as evidenced by a year-to-date change of -72.55%.
ACTU stock price ended at $1.54 on Tuesday, after rising +1.32%
Actuate Therapeutics Inc (ACTU) last closed at $1.54, gaining +1.32%. These facts feed the 1-day and 1-week ACTU price prediction above.
Forecast Drivers
Actuate Therapeutics Inc (ACTU) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ACTU, ranked by similarity.
Seasonality analysis for ACTU
Historically the probability of a positive September return for ACTU is 11.90%. January offers the highest probability of a positive month at 57.50%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ACTU
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $5.08 | $6.12 | $7.02 | +297.23% |
| Oct 2026 | $5.72 | $6.86 | $7.69 | +345.36% |
| Nov 2026 | $5.77 | $6.69 | $7.86 | +334.18% |
| Dec 2026 | $5.97 | $6.70 | $7.46 | +335.36% |
In 2026, Actuate Therapeutics Inc (ACTU) is projected to range from $5.08 to $7.86.
Actuate Therapeutics Inc 2026 monthly forecast
In Sep 2026, Actuate Therapeutics Inc is projected to average $6.12, with a low of $5.08 and high of $7.02.
In Oct 2026, Actuate Therapeutics Inc is projected to average $6.86, with a low of $5.72 and high of $7.69.
In Nov 2026, Actuate Therapeutics Inc is projected to average $6.69, with a low of $5.77 and high of $7.86.
In Dec 2026, Actuate Therapeutics Inc is projected to average $6.70, with a low of $5.97 and high of $7.46.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.